retatrutide phase 2 nejm weight loss 48 weeks isn't a GLP-1. It's not a dual agonist. It's a triple hormone receptor agonist — activating GIP, GLP-1, and glucagon simultaneously. Three receptors. Three mechanisms. One protocol. Swipe to see what Retatrutide vs. Tirzepatide: The Next-Gen

(2001) investigated AOD9604 in obese Zucker rats and observed that chronic administration was associated with reduced body weight gain without changes in IGF-1 levels or glucose tolerance, distinguishing its activity profile from that of full-length growth hormone [1]

#DigestiveHealth #Gastroenterology #HealthcareInnovation #IntegratedCare #MedicalEthics #MetabolicEndoscopy #ObesityManagement #PatientCenteredCare #Publications #RegulatoryAgencies #MarketAccess #MarketAccessToday Gastroenterologists Take Charge in Managing Obesity with Innovative Approaches To view or add a comment, sign in Why TESTOSTERONE matters in orthobiologics

[4] Lifestyle and Adherence Factors: Your dietary habits and physical activity level can significantly impact how quickly you notice effects

[DOI] [PubMed] [Google Scholar] [156].Cao M, Mu X, Jiang C, Yang G, Chen H, Xue W, Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis